As a devices and solutions provider with a deep focus on healthcare, Mindray strives to develop medical technologies and share better healthcare for more people. Mindray was founded in 1991, and headquartered in Shenzhen. With 29 years’ development, Mindray has achieved a good marketing performance with increasing globe influence. Mindray’s 39 subsidiaries are serving over 190 countries and regions around the world. Over 10,000 employees from 30 countries choose to join us, and a quarter of them are R&D experts who explore the most advanced medical technology. Top-tier medical institutes recognize our performance in Europe, the U.S. , China and more. Mindray can provide comprehensive and high-quality products, solutions and services for different departments and different hospitals. Its business segments cover three main product lines including Patient Monitoring & Life Support, In-vitro Diagnostics, and Medical Imaging System. Besides the main three product lines, it also has other products for vet solutions and orthopedic products. These products also have very good marketing performance. Now our patient monitoring and life support solutions, anesthesia machine and hematology analyzer all ranked No 3 in global market. Hematology and Chemistry analyzer ranked No2 and No3 in China. Mindray is committed to consistent investment in R&D, a guarantee of our continuous innovation. Our R&D experts listen to the customer and advance healthcare technology based on customer needs. Supported by in-depth research, detailed analytics and actionable data - combined with direct customer input - we arrive at solutions designed to overcome real-world obstacles to delivering better patient care. And we have already set 8 R&D centers worldwide with cutting edge of technology and have over 2,500 R&D engineers, Mindray insists on investing about 10% of the annual revenue in R&D. The total number of our patents is close to 5,000, of which 15% are recognized in the US and Europe. The vision and mission of Mindray are “Better Healthcare for All” and ”Advance medical technologies to make healthcare more accessible”. We are committed to bring reachable healthcare to everyone. Because we believe every life is valuable and deserves best medical care. Mindray also has advanced intelligent manufacturing. The manufacturing centers are based in both Shenzhen and Nanjing with over 300,000 square meters, which is the largest medical manufacturing center in Asia Pacific. Now Mindray’s products and services can be found in over 190 countries and regions. Our localized teams are dedicated to the local market. We keep thinking globally and acting locally to better understand our customers and address their needs accordingly.
The advanced BC-6800Plus not only provides more reliable routine CBC plus 5-part DIFF results, but also has a higher throughput of up to 200 samples per hour. Based on the new SF Cube technology platform, the BC-6800Plus could provide more reliable blood cell results and abnormal cells flagging results with anticipated warning messages, exceeding clinicians’ expectations and setting a new standard for blood analysis. With the newly designed opticals and reagent systems, the SF Cube technology can help doctors to better differentiate the clusters of cells, which is the key to revealing more abnormal cell · NRBC result in every CBC · NLR parameter in each CBC+DIFF · More accurate RET and PLT-O result · Automatic Rerun & Reflex